IBXXFImagion Biosystems Ltd.

About Imagion Biosystems Ltd. (IBXXF)

Imagion Biosystems Ltd. (IBXXF) is a Diagnostics & Research company headquartered in Melbourne, VA, Australia whose shares trade over-the-counter on the Pink tier.

Imagion Biosystems Limited provides medical imaging technologies using magnetic resonance. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX, an iron oxide nanoparticle to detect cancer. Imagion Biosystems Limited has a collaborative research program with Patrys Limited to use the MagSense nanoparticles for enhancing brain tumor imaging and diagnosis.

IBXXF key facts

Ticker symbol

IBXXF

Market tier

Pink

Sector

Healthcare

Industry

Diagnostics & Research

Headquarters

Melbourne, VA, Australia

Country of incorporation

AU

Estimated market cap

$8.97M (as of May 12, 2025)

Shares outstanding

1,121,261,822

Reporting standard

International Reporting: ASX - Australian Securities Exchange

Audit status

Audited

Fiscal year end

12/31

Explore more: Diagnostics & Research stocks · Healthcare sector · Pink stocks · OTC stocks starting with I